INDIANAPOLIS, Jan. 4, 2024
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today
announced LillyDirect™, a new digital healthcare experience for
patients in the U.S. living with obesity, migraine and
diabetes. LillyDirect offers disease management resources,
including access to independent healthcare providers*, tailored
support, and direct home delivery of select Lilly medicines through
third-party pharmacy dispensing services.
"A complex U.S. healthcare system adds to the burdens patients
face when managing a chronic disease. With LillyDirect, our goal is
to relieve some of those burdens by simplifying the patient
experience to help improve outcomes," said David A. Ricks, Lilly's chair and CEO.
"LillyDirect offers more choices in how and where people access
healthcare, including a convenient home delivery option to fill
Lilly medicines they have been prescribed."
For patients living with obesity, migraine and diabetes,
LillyDirect offers:
- LillyDirect Pharmacy Solutions, a digital pharmacy for select
Lilly medicines powered by third party online pharmacy fulfillment
services. LillyDirect Pharmacy Solutions gives patients a simple
option to get consistent access to Lilly medicines they have been
prescribed with the added convenience of home delivery. By
obtaining medicines directly from Lilly, patients can easily access
Lilly's affordability solutions and savings card opportunities are
automatically applied for patients who qualify. Medicines fulfilled
by pharmacy service providers through LillyDirect Pharmacy
Solutions ship free of charge.
- Disease state and healthcare educational information to help
empower and support patients on their care journeys.
- Access to independent telehealth providers that could
complement a patient's current primary care team or be an
alternative to in-person care for certain conditions.
- An independent search tool that allows a patient to find
healthcare professionals near them if they prefer in-person
care.
"We know that people have come to depend on the efficiency and
convenience of digital solutions to meet a variety of their
everyday needs – healthcare being one of them," said Frank Cunningham, group vice president, global
value and access at Lilly. "We launched LillyDirect with the hope
that it will offer patients an innovative end-to-end experience to
manage their health and access their medicines, so they can get
back to living their lives."
LillyDirect will continue to be updated and expanded to improve
the customer experience. Future updates may include new products,
partners and services, such as programs designed to help patients
with adherence to their medicines.
About Lilly
Lilly unites caring with discovery to create medicines that make
life better for people around the world. We've been pioneering
life-changing discoveries for nearly 150 years, and today our
medicines help more than 51 million people across the globe.
Harnessing the power of biotechnology, chemistry and genetic
medicine, our scientists are urgently advancing new discoveries to
solve some of the world's most significant health challenges,
redefining diabetes care, treating obesity and curtailing its most
devastating long-term effects, advancing the fight against
Alzheimer's disease, providing solutions to some of the most
debilitating immune system disorders, and transforming the most
difficult-to-treat cancers into manageable diseases. With each step
toward a healthier world, we're motivated by one thing: making life
better for millions more people. That includes delivering
innovative clinical trials that reflect the diversity of our world
and working to ensure our medicines are accessible and affordable.
To learn more,
visit Lilly.com and Lilly.com/news or follow us
on Facebook, Instagram and LinkedIn. C-LLY
Cautionary Statement Regarding Forward-Looking
Statements
This press release contains forward-looking statements (as that
term is defined in the Private Securities Litigation Reform Act of
1995) about LillyDirect capabilities and offerings and reflects
Lilly's current beliefs and expectations. However, there can be no
assurance that LillyDirect will achieve Lilly's objectives or that
Lilly will execute its strategy as planned. For further discussion
of risks and uncertainties relevant to Lilly's business that could
cause actual results to differ from Lilly's expectations, see
Lilly's Form 10-K and Form 10-Q filings with the United States
Securities and Exchange Commission. Except as required by law,
Lilly undertakes no duty to update forward-looking statements to
reflect events after the date of this release.
* The telehealth vendors listed on the LillyDirect site are
independent. Treatment decisions and prescribing practices are made
based on the independent medical judgment of the telehealth
provider's care team. They may prescribe medication or another
course of treatment.
Refer
to:
|
Molly McCully,
mccully_molly@lilly.com; 317-478-5423 (Media)
|
|
Joe Fletcher;
jfletcher@lilly.com; 317-296-2884 (Investors)
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lilly-launches-end-to-end-digital-healthcare-experience-through-lillydirect-302025738.html
SOURCE Eli Lilly and Company